Stock ALIKO IKONISYS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ikonisys S.A. Stock

Equities

ALIKO

FR00140048X2

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 04:03:56 2024-04-30 EDT 		5-day change 1st Jan Change
1.4 EUR -2.10% Intraday chart for Ikonisys S.A. -2.10% -10.26%
04-30 Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report CI
02-19 Ikonisys Says Hospitex Wins Italian Tender for Diagnostic Systems MT

Financials

Sales 2023 * 1M 1.07M 1.47M Sales 2024 * 4.9M 5.25M 7.21M Capitalization 14.63M 15.68M 21.54M
Net income 2023 * -1M -1.07M -1.47M Net income 2024 * - 0 0 EV / Sales 2023 * 16.2 x
Net Debt 2023 * 1.6M 1.71M 2.36M Net cash position 2024 * - 0 0 EV / Sales 2024 * 2.99 x
P/E ratio 2023 *
-8.75 x
P/E ratio 2024 *
70 x
Employees 11
Yield 2023 *
-
Yield 2024 *
-
Free-Float 16.92%
More Fundamentals * Assessed data

Chart Ikonisys S.A.

Dynamic Chart

Latest news about Ikonisys S.A.

Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report CI
Ikonisys Says Hospitex Wins Italian Tender for Diagnostic Systems MT
Ikonisys: production record for Hospitex CF
Ikonisys: private placement for one million euros CF
Diagnostics Group Ikonisys Raises EUR1 Million Via Share Issue MT
Ikonisys S.A. Announces the Completion of ?1 Million Private Placement to Speed Up Growth Following Recent Pivotal Deals CI
Ikonisys S.A. announced that it expects to receive ?1.000001 million in funding CI
Hospitex International, Pathologists Beyond Borders Association Team Up to Develop Early Cancer Diagnosis Systems MT
Ikonisys Strikes EUR5 Million Deal to Buy Italian Peer Hospitex International MT
Ikonisys S.A. entered into an agreement to acquire Hospitex International S.R.L. for ?3.5 million. CI
Ikonisys SA and Biocare Medical Forge Alliance CI
Ikonisys S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ikonisys US Subsidiary Completes ISO Recertification MT
Ikonisys Completes Study for Immuno-Oncology Platform to Detect Extremely Rare Cells MT
Ikonisys Raises New Financing Via Columbia Threadneedle MT
More news

Analyst Recommendations on Ikonisys S.A.

IKONISYS : Soft H1, but on track to achieve mid-term targets AL
IKONISYS : Factoring in the revised commercialisation plans AL
More recommendations

Press releases Ikonisys S.A.

Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report BU
Ikonisys S A : Inside Information / News release on accounts, results PU
Ikonisys S A : announces the launch of its instrument for high-volume customers, the Ikoniscope20max PU
Ikonisys S A : announces the first sale of the Ikoniscope20 solution including the newly added reagents to Comprehensive Urology PU
Ikonisys S A : publishes its Full-Year Financial Results for 2021 and provides an update on its latest developments PU
More press releases

News in other languages on Ikonisys S.A.

Ikonisys annonce le report de la publication de son rapport financier annuel
Correctif: Ikonisys: sa future filiale Hospitex décroche un contrat en Italie
Ikonisys: sa future filiale Hospitex décroche un contrat en Croatie
Ikonisys SA (von Sphene Capital GmbH): Buy
Ikonisys : record de production pour Hospitex
More news

Quotes and Performance

1 day-2.10%
1 week-2.10%
Current month-5.41%
1 month-5.41%
3 months-2.78%
6 months+17.65%
Current year-10.26%
More quotes

Highs and lows

1 week
1.40
Extreme 1.4
1.43
1 month
1.38
Extreme 1.38
1.49
Current year
1.25
Extreme 1.25
1.66
1 year
1.14
Extreme 1.14
1.80
3 years
1.14
Extreme 1.14
4.70
5 years
1.14
Extreme 1.14
4.70
10 years
1.14
Extreme 1.14
4.70
More quotes

Managers and Directors - Ikonisys S.A.

Managers TitleAgeSince
Michael W. Kilpatrick FOU
 Founder - 21-05-30
Mario Crovetto CEO
 Chief Executive Officer 71 21-06-30
Alessandro Mauri DFI
 Director of Finance/CFO - -
Members of the board TitleAgeSince
Mario Mauri CHM
 Chairman 74 21-05-30
Roberto Rettani BRD
 Director/Board Member 71 21-05-30
Mario Crovetto CEO
 Chief Executive Officer 71 21-06-30
More insiders

Quotes

Date Price Change Volume
24-04-30 1.4 -2.10% 2,264
24-04-29 1.43 -.--% 26,128
24-04-26 1.43 -.--% 672
24-04-25 1.43 -.--% 1
24-04-24 1.43 -.--% 7,224

Real-time Euronext Paris, April 30, 2024 at 04:03 am

More quotes

Company Profile

Ikonisys S.A. is specialized in the design, manufacture and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. Net sales break down by source of revenue as follows: - sales of products (65.3%): sales of Ikoniscope instruments and the related software application; - sales of maintenance services (34.7%).
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-10-24 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Ikonisys S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.4 EUR
Average target price
6.3 EUR
Spread / Average Target
+350.00%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
IKONISYS S.A. Stock Ikonisys S.A.
-10.26% 15.65M
BIOMÉRIEUX Stock bioMérieux
-0.60% 12.63B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.67B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.82% 5.42B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-51.89% 3.51B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.59B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.05B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+1.67% 1.77B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. ALIKO Stock